Leo THOMAS;Rolf GREMPLER;Michael MARK;Uli Christian BROEDL;Peter EICKELMANN;Leo John SEMAN
发明人:
Peter EICKELMANN,Michael MARK,Leo John SEMAN,Leo THOMAS,Uli Christian BROEDL,Rolf GREMPLER
申请号：
US14046109
公开号：
US20140031301A1
申请日:
2013.10.04
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
